Live Quote · NASDAQNEUPHealthcare· Biotechnology

Neuphoria Therapeutics Inc.

$2.35▲ 1.29%(+$0.03)
MKT CAP $12.72MNEXT EARNINGS Feb 16, 2027
50%
Bullish
TickerSpark Score
49/100
▌ Weak
88
Valuation
35
Profitability
10
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NEUP research report →

Analyst Price Target
$7.00+197.9% vs. today

Range $7 – $7

Analyst RatingBuy
1 Buy1 Hold0 Sell

Price Chart

-44.18% · this period
$5.48$3.88$2.27Nov 20May 26Nov 20
52-Week Range3% of range
Low
$2.26
Current
$2.35
High
$5.53